Plain-English translation of NCT06940609 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a treatment called accelerated iTBS (a type of magnetic brain stimulation) to help people recover from Long COVID, particularly the cognitive and neurological symptoms that linger after a COVID infection. The treatment uses magnetic pulses delivered to a specific part of the brain to reduce inflammation and improve thinking, mood, and quality of life. Half of participants will receive the real treatment, and half will receive a sham (placebo) treatment that feels similar but has no actual brain effects—this allows researchers to see if the real treatment actually works.
Long COVID causes lasting brain fog, cognitive problems, and psychiatric symptoms in many people, and currently there are no proven treatments. This study is exploring whether targeted magnetic brain stimulation might help reduce inflammation in the brain and restore lost function.
You likely qualify if…
You likely don't qualify if…
You will receive 50 sessions of magnetic brain stimulation over 10 days (5 sessions per day). The first 25 sessions are blinded, meaning you won't know if you're receiving the real treatment or the sham treatment. The second 25 sessions are open-label, meaning everyone knows they're receiving the real treatment. Throughout the study, you'll have brain imaging scans and complete tests measuring your symptoms, mood, thinking, and quality of life to see if the treatment helps.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States